T1	Participants 69 97	patients with rectal cancer.
T2	Participants 253 280	mid and low rectal cancers.
T3	Participants 289 415	Some 204 patients with mid and low rectal adenocarcinomas were allocated randomly to open (103) or laparoscopic (101) surgery.
T4	Participants 468 509	Most patients had stage II or III disease
